PTC Therapeutics has formed a research collaboration and licensing agreement with Pfizer centered on PTC's gene expression modulation by small molecules (GEMS) technology. Pfizer has paid $10 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback